Publications by authors named "Amir R Aref"

22Publications

Mesenchymal stem cells induce PD-L1 expression through the secretion of CCL5 in breast cancer cells.

J Cell Physiol 2020 Nov 4. Epub 2020 Nov 4.

School of Biomedical Engineering, University of Technology Sydney, Sydney, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jcp.30135DOI Listing
November 2020

Photoluminescent functionalized carbon dots for CRISPR delivery: synthesis, optimization and cellular investigation.

Nanotechnology 2019 Mar 4;30(13):135101. Epub 2019 Jan 4.

Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran. Department of Medical Nanotechnology, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran. Advances Nanobiotechnology and Nanomedicine Research Group (ANNRG), Iran University of Medical Sciences, Tehran, Iran.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1088/1361-6528/aafbf9DOI Listing
March 2019

Integrated use of bioinformatic resources reveals that co-targeting of histone deacetylases, IKBK and SRC inhibits epithelial-mesenchymal transition in cancer.

Brief Bioinform 2019 03;20(2):717-731

Drug Design and Bioinformatics Unit, Medical Biotechnology Department, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/bib/bby030DOI Listing
March 2019

Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids.

Cancer Discov 2018 02 3;8(2):196-215. Epub 2017 Nov 3.

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-17-0833DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5809290PMC
February 2018

Carbon nanotubes in microfluidic lab-on-a-chip technology: current trends and future perspectives.

Microfluid Nanofluidics 2017 Sep 5;21(9). Epub 2017 Sep 5.

Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10404-017-1989-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6415915PMC
September 2017

Nanomedicine and advanced technologies for burns: Preventing infection and facilitating wound healing.

Adv Drug Deliv Rev 2018 01 4;123:33-64. Epub 2017 Aug 4.

Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, Boston, USA; Department of Dermatology, Harvard Medical School, Boston, USA; Harvard-MIT Division of Health Sciences and Technology, Cambridge, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S0169409X173012
Publisher Site
http://dx.doi.org/10.1016/j.addr.2017.08.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5742034PMC
January 2018

Microfluidic systems for stem cell-based neural tissue engineering.

Lab Chip 2016 07;16(14):2551-71

Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA 02114, USA. and Department of Dermatology, Harvard Medical School, Boston, MA 02115, USA and Harvard-MIT Division of Health Sciences and Technology, Cambridge, MA 02139, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1039/c6lc00489jDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4935609PMC
July 2016

Carbon nanotubes part II: a remarkable carrier for drug and gene delivery.

Expert Opin Drug Deliv 2015 Jul 22;12(7):1089-105. Epub 2015 Jan 22.

Iran University of Medical Sciences, School of Advanced Technologies in Medicine, Department of Nanotechnology , Tehran , Iran.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/17425247.2015.1004309DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4475451PMC
July 2015

Carbon nanotubes part I: preparation of a novel and versatile drug-delivery vehicle.

Expert Opin Drug Deliv 2015 Jul 19;12(7):1071-87. Epub 2015 Jan 19.

Iran University of Medical Sciences, School of Advanced Technologies in Medicine, Department of Nanotechnology , Tehran , Iran.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/17425247.2015.1003806DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4475469PMC
July 2015

Inhibition of KRAS-driven tumorigenicity by interruption of an autocrine cytokine circuit.

Cancer Discov 2014 Apr 20;4(4):452-65. Epub 2014 Jan 20.

Departments of 1Medical Oncology and 2Cancer Biology, Dana-Farber Cancer Institute; 3Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston; 4Broad Institute of Harvard and MIT, Cambridge; 5MGH Cancer Center, 6Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Charlestown, Massachusetts; and 7Department of Surgery, Division of Biology and Biomedical Sciences, Washington University, St. Louis, Missouri.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-13-0646DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3980023PMC
April 2014

Complementary effects of ciclopirox olamine, a prolyl hydroxylase inhibitor and sphingosine 1-phosphate on fibroblasts and endothelial cells in driving capillary sprouting.

Integr Biol (Camb) 2013 Dec;5(12):1474-84

Biosystems & Micromechanics Interdisciplinary Research Group (BioSyM), Singapore-MIT Alliance in Research & Technology (SMART), Singapore.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1039/c3ib40082dDOI Listing
December 2013